MAPT and Alzheimer disease: The exacerbation of p‐Tau elevation in APOE4+ patients was observed at multiple AD‐associated epitopes including pSer396, AT8 (pSer202 & pThr205) and pThr231, even though total tau detected by Tau5 antibody remained unchanged (Figure 1F–J).